STUDIES OF RAT AORTIC SEGMENTS in vitro (1, 40, 41) have demonstrated a characteristic regional pattern of functional differentiation of the endothelium for the generation of three classes of signals capable of regulating the cGMP content of the underlying vascular smooth muscle. Endothelial formation of nitric oxide (NO) from L-arginine (1) and of glutamate from L-leucine (41) increase cGMP, which is reported to mediate relaxation of vascular smooth muscle (21, 35, 38) . Endothelial formation of prostaglandin H 2 (PGH 2 ) via the cyclooxygenase arm of the eicosanoid pathway decreases cGMP (40) . All three pathways exhibit a similar regional pattern of activity: maximal values just distal to the aortic arch, i.e., in the "windkessel region," and progressively decreasing values distally. On the basis of these observations and the functional importance of the windkessel elastic reservoir, whose compliance and other viscoelastic properties influence hemodynamic parameters, such as the arterial systolic and pulse pressures, work of the left ventricle, and pulse-wave velocity (15) , we have hypothesized (41) that an interplay of the NO, leucine-to-glutamate (Leu3 Glu), and PGH 2 signal pathways mediates the dynamic regulation of smooth muscle contractility and aortic compliance in the windkessel region.
The Leu3 Glu pathway, the most recently described of these mechanisms, is composed of the endothelial uptake of L-[U- 14 C]leucine, the relatively efficient utilization of the leucine carbons for synthesis of [ 14 C]glutamate, and the transfer of the glutamate to the underlying smooth muscle via a compartmentalized mechanism (41) . This study characterizes the metabolic route of the Leu3 Glu pathway and examines its role in the regulation of aortic contractile responses. It is well established that leucine, an essential, "ketogenic" amino acid, is metabolized via 3-hydroxy-3-methylglutaryl (HMG) coenzyme A (CoA) to acetyl CoA and acetoacetate by a reaction sequence localized largely in the mitochondria (12, 47) . Acetyl CoA so derived can enter the tricarboxylic acid cycle by the condensation reaction with oxaloacetate and result in the formation of ␣-ketoglutarate, which can be converted to glutamate by the glutamate dehydrogenase reaction or by transamination. The studies below show that the aortic Leu3 Glu conversion utilizes this route. Aortic segments incubated in vitro with radioactive leucine labeled at different positions or with other radioactive precursors yield radioactive glutamate and CO 2 as predicted qualitatively and quantitatively by the catabolic sequence. Thus [U- 14 C]leucine, which is ketogenic, yields [ 14 C]glutamate efficiently; [U- 14 C]isoleucine, only partially ketogenic, yields considerably less labeled glutamate; and [U-sequence: cellular uptake of leucine, transamination to ␣-ketoisocaproate, and conversion of the latter to isovaleryl CoA via oxidative decarboxylation by the branched-chain dehydrogenase complex (BCDC). The BCDC reaction is the controlling reaction whose activity accounts for the regional Leu3 Glu pattern of the rat aortic endothelium.
To examine the role of the Leu3 Glu pathway in the regulation of aortic smooth muscle contractility, we studied the effects of blocking the pathway on the contractile responses of aortic segments in vitro. Given prior evidence that Leu3 Glu blockade owing to treatment with leucine analogs decreases the smooth muscle cGMP content (41), we predicted increased contractile responses. In the present study, three different classes of compounds capable of interrupting the Leu3 Glu pathway were examined to ensure the specificity of the inhibition: 1) the leucine analogues L-leucinol and L-leucinamide, previously shown to block the conversion of [U- 14 C]leucine to [ 14 C]glutamate and to decrease aortic segment cGMP (41) ; 2) ␣-ketoisovalerate and its amino acid precursor L-valine, which do not yield acetyl CoA or glutamate but are metabolized by the same BCDC (36) that functions in the controlling reaction of the Leu3 Glu pathway; and 3) D-aspartate, a relatively specific and metabolically inert inhibitor of Na ϩ -dependent glutamate transporters (17, 28, 42 ). The results demonstrate that interruption of the pathway by all three classes of compounds significantly enhances the contractile responses of aortic segments in vitro precontracted with phenylephrine or serotonin (5-hydroxytryptamine; 5-HT). The enhanced contractile responses elicited by each of the three inhibitor classes require an intact endothelium and are independent of the NO pathway, i.e., they are not influenced by inhibiting NO formation.
MATERIALS AND METHODS
Animals. Sprague-Dawley strain male rats weighing ϳ250 g were obtained from Charles River and maintained on a nutritionally complete pellet diet (Purina rat chow 50001) and water ad libitum. Rats weighed 250-450 g when used in the experiments.
Preparation and incubation of aortic slices. Rats were anesthetized rapidly by inhalation of carbon dioxide and were then exsanguinated. The aorta was excised from its origin at the aortic valve ring to the approximate level of the left renal artery, and the segment, ϳ7.5 cm long, was chilled immediately in 145 mM NaCl-5 mM KCl and maintained at 2°C until the onset of incubation ϳ10-20 min later. The adherent adventitial tissue was removed, the vessel was cut open longitudinally and sliced into horizontal segments, and each segment was bisected vertically for comparison of a control and experimental sample at a given level of the aorta. Comparable slices from 3-4 rats were usually pooled to provide sufficient tissue for analysis. To study the formation of [ 14 C]glutamate, the slices were suspended in 2.5 ml of an incubation medium of the following general composition (in mM): 118 NaCl, 4.7 KCl, 2.0 CaCl2, 1.2 MgSO4, 1.2 KH2PO4, 25 NaHCO3, and 10 D-glucose. The medium also contained unlabeled precursor, e.g., 50 or 100 M L-leucine, and a radioactive compound, e.g., 0.3 Ci/ml of L-[U-
14 C]leucine, specific radioactivity 314 mCi/mmol (Amersham). Suspensions were generally shaken for 60 min at 37°C in an atmosphere of 5% CO 2-95% O2. Thereafter, the tissues were removed, blotted to remove adherent medium, weighed rapidly, and frozen immediately in vials immersed in an ethanol-dry ice bath. Frozen tissues were maintained at Ϫ15°C until assayed. When appropriate, the endothelium was denuded before incubation of the slices, as previously described (1) . Tissue uptake of [ 14 C]leucine and estimation of the [ 14 C]glutamate formed were determined as described previously (41) . Uptake was quantified by the disappearance of labeled precursor from the ambient medium and [
14 C]glutamate formation by the preparation of aqueous extracts of the tissues, resolution of the extracts by either thin-layer chromatography and autoradiography or by anion exchange column chromatography and quantification of the radioactive glutamate fractions by liquid scintillation spectrometry. [ 14 C]Glutamate formation (expressed as nmol/g wet weight of tissue) was calculated from radioactivity so quantified and the specific radioactivity of the precursor or of an acetyl group of the precursor [U- 14 These conditions were also used to assay flux across the BCDC with 100 M ␣-ketoisocaproate plus ␣-keto-[1-
14 C]isocaproate as substrate, similar to methods previously reported by others (4, 19) . We use the general term "BCDC activity" to express the net flux assessed via 14 CO2 so evolved by segments of whole tissue. This BCDC activity is determined by several factors, including the amount of BCDC enzyme protein, the degree of phosphorylation of the regulatory site, i.e., the activity state (19) , the availability of the ␣-ketoisocaproate substrate owing to net transamination of leucine (i.e., the forward minus the back reaction), the transport of ␣-ketoisocaproate across the mitochondrial membrane via the branched chain ␣-keto acid transporter (20) and the concentration of cofactors for the oxidative decarboxylation.
Preparation and assay of aortic homogenates. Aortic segments were homogenized in a sucrose medium containing antiproteases (2) and the suspensions centrifuged at 800 g for 10 min at 2°C to remove tissue clumps. The supernatant suspensions containing ϳ1.0 mg/ml of protein were then assayed for leucine-␣-ketoglutarate transaminase and alanine-␣-ketoglutarate transaminase activities in 0.15 ml of the following reaction mixture (in mM): 133 Tris buffer (pH 7.6), 0.13 pyridoxal phosphate, 6.58 Na ϩ ␣-ketoglutarate, 6.58 L-leucine or L-alanine, and 0.132 Ci/ml of ␣-keto-[1-
14 C]glutarate (specific radioactivity 51.8 mCi/mmol; New England Nuclear). Reaction was initiated by addition of homogenate containing 100 g of protein and the mixtures incubated with shaking at 37°C for 20 min. Thereafter, aqueous extracts were prepared and assayed for [
14 C]glutamate as previously described (41) .
Estimation of glutamate. Tissue content of free glutamate was estimated enzymatically using glutamate dehydrogenase, as described by Lund (31) . Approximately 50-60 mg of aortic tissue were suspended and mixed in 1.0 ml of 10% perchloric acid at 2°C for 1 h. After centrifugation (11,500 g for 10 min) the supernatant solutions were neutralized with KOH, insoluble potassium perchlorate was removed by centrifugation, and the neutralized supernatants were lyophilized. The reaction mixture for enzyme assay (total volume 1.1 ml; final pH 8.7) had the following composition: 90 mM Tris buffer, 1.8 mM EDTA, 0.57 M hydrazine, 1.5 mM ␤-nicotinamide adenine dinucleotide, 0.5 mM ADP, and an appropriate aliquot of either sample, L-glutamate standard, or water (control). Reaction at room temperature was initiated by the addition of 200 g (20 l) of beef liver glutamate dehydrogenase (120 U/mg; Boehringer-Mannheim) and the increase in optical absorbance at 339 nm owing to the formation of reduced nicotinamide adenine dinucleotide followed spectrophotometrically.
Contractile responses of aortic rings. After the rats were anesthetized by inhalation of carbon dioxide and were exsanguinated, the aorta was excised, adherent adventitial tissue was removed, and the vessel was placed into the isotonic incubation medium (see Preparation and incubation of aortic slices) equilibrated with 5% CO 2-95% O2 at 23°C and containing 50 M L-leucine and 0.1 mM ascorbate. The windkessel region, i.e., the segment from ϳ15-45 mm from the aortic ring, was used, unless indicated otherwise, and 7-mm rings (mean wet wt 10.1 Ϯ 0.6 mg) were cut. Each ring was mounted by means of stainless steel hooks to record isometric tension in a water-jacketed 50-ml chamber maintained at 37°C. The incubation medium described above was equilibrated with 5% CO 2-95% O2 and recirculated through the chamber from a 300-ml reservoir at a rate of 32 ml/min. Isometric tension was recorded via a force transducer linked to a Macintosh computer using MacLab software. The aortic segments were mounted within 10-15 min after the death of the animal. Initial tension was adjusted to 1.0 g and so maintained for 60-90 min. Thereafter, the recirculated medium was replaced with fresh medium and control observation periods begun. Segments were generally precontracted with either phenylephrine (10 Ϫ8 -10 Ϫ6 M) or 5-HT (5-10 M). Test compounds were added when plateau precontraction tension values were attained.
When indicated, the endothelium was denuded before mounting the aortic ring by abrading with the steel supporting hooks. The procedure did not interfere with subsequent contraction responses to phenylephrine or 5-HT, and the effectiveness of the denuding procedure was demonstrated in each instance by the failure of 10 Ϫ5 M acetylcholine to induce a relaxation response.
Materials. In addition to [U- (Fig. 1B) , a parameter independent of tissue weight varies with the extent to which each precursor is metabolized to acetoacetate and acetyl CoA, i.e., is "ketogenic." From the known metabolic pathways (34, 47) for catabolism of these three amino acids 5/6 carbons of leucine, 2/6 carbons of isoleucine, and 0/5 carbons of valine are utilized for acetyl CoA formation. On the premise that glutamate formation occurs via the acetyl CoA so formed, the relative incorporation of 14 C from leucine/isoleucine/valine is therefore predicted to be 1. The foregoing values indicate that the regional differentiation pattern of CO 2 evolution is not due solely to differences in leucine uptake by the endothelium. To examine the role of BCDC activity more directly, sequential aortic segments were also incubated with the immediate substrate for the enzyme, ␣-keto-[1-
14 C]isocaproate, in each of four experiments and values of the Aortic segments were prepared and tested as described in the legend to Fig. 2 . Values (nmol/g wet weight of tissue) for [
14 C]glutamate and 14 CO2 formed, respectively, were calculated using the specific radioactivity of a 2-carbon and 1-carbon constituent of the precursor [U-
14 C]leucine. F, Intact segments; E, denuded segments.
lium. Analysis of the data of Fig. 2A and Fig. 3 leads to the following stoichiometry of leucine utilization by the aortic endothelium of the segments studied: each mole of leucine entering the Leu3 Glu pathway via oxidative decarboxylation by the BCDC yields as final products 1 mol of glutamate, containing a 2-carbon moiety of leucine, plus 4 mol of CO 2 . Fig. 3 ) is predicted to be 0.25; from the areas under the curves in Fig. 3 Studies with ␣-ketoglutarate. Inasmuch as the initial steps of the Leu3 Glu pathway are endothelial uptake of leucine and transamination by reaction with a suitable ␣-ketoacid, such as ␣-ketoglutarate, we studied whether the activity of the transamination reaction is rate limiting in the pathway. Successive aortic segments were incubated with [1- 14 C]leucine in the presence and absence of 2-5 mM ␣-ketoglutarate and the 14 CO 2 produced was quantified. Evolution of 14 CO 2 in four experiments followed the activity pattern illustrated in Fig. 2A both in the absence and presence of added ␣-ketoglutarate. Addition of ␣-ketoglutarate did not increase significantly the 14 CO 2 produced in the windkessel segment, 15-60 mm from the valve ring. Transaminase activities of homogenates prepared from five successive aortic segments were also tested as described in Preparation and assay of aortic homogenates by following the formation of [
14 C]glutamate from ␣-keto-[1-
14 C]glutarate and leucine or alanine. The mean values observed (52.0 Ϯ 9.3 and 75.0 Ϯ 11.5 nmol ⅐ mg Ϫ1 ⅐ min Ϫ1 , respectively) for leucine and alanine transaminases did not vary significantly with segment or exhibit the differentiation pattern of the windkessel region.
The last biochemical reaction of the Leu3 Glu pathway would be conversion of ␣-ketoglutarate to glutamate via a transamination or glutamate dehydrogenase reaction. We explored the possibility that the activity of this reaction might exhibit the differentiation pattern of the windkessel region. In each of three experiments, successive aortic segments were incubated in the presence of 0.1 mM ␣-keto-[1- In six additional experiments (18 rats) the effects on glutamate content of denuding the endothelium before incubation were examined. A 20-mm aortic segment from the peak area ϳ20-40 mm from the aortic valve ring was split longitudinally and one-half denuded. The glutamate contents after 1 h of incubation of the intact and denuded segments, respectively, were 0.90 Ϯ 0.15 and 0.25 Ϯ 0.04 mol/g wet weight (P Ͻ 0.005). The reduction of ϳ72% indicates that endothelial formation of glutamate in vitro is a major determinant of the aortic content. In five further experiments (15 rats) aortic segments were tested similarly, except that one-half of each was denuded after incubation. The resulting glutamate values in the intact and denuded samples, respectively, were 0.81 Ϯ 0.14 and 0.79 Ϯ 0.20 mol/g, not significantly different. The results indicate that following formation in the endothelium glutamate is transferred to the underlying aortic coats. This conclusion is also supported by studies of [ Effects of L-leucinol. L-Leucinol effectively inhibits the Leu3 Glu pathway and lowers the cGMP content of aortic segments in vitro (41) . The effects of 5 mM leucinol on the glutamate content and BCDC activity of aortic segments were explored. In five experiments (15 rats), values of the glutamate contents of control versus leucinol-treated segments, tested as described in the preceding paragraph, were 1.17 Ϯ 0.24 versus 0.57 Ϯ 0.17 mol/g (P Ͻ 0.01). The effects of 5 mM leucinol on BCDC activity were examined by incubating aortic segments with either [1- 14 C]isocaproate (5 experiments; control and leucinol values, respectively, 163 Ϯ 24 and 12.1 Ϯ 2.1 nmol/g, P Ͻ 0.005). Inhibitory effects of leucinol could result from blocking the uptake or transamination of leucine, e.g., by blocking the mitochondrial branched chain aminotransferase, which functions as a branched-chain ␣-ketoacid transporter (20) . Direct binding to the BCDC protein is unlikely because leucinol lacks a keto group.
Other tissues. Prior results show that the Leu3 Glu pathway is present mainly in four tissues: the aorta, pancreas, testis, and lung (41) . Inasmuch as the present evidence (Figs. 2 and 3) indicates that the differentiation of aortic segments for Leu3 Glu activity is correlated with leucine uptake and BCDC activity, it was of interest to examine these activities in tissues differentiated or not for the Leu3 Glu pathway. Segments of 11 rat tissues were incubated with either [U- 14 C]leucine. The four tissues with an active Leu3 Glu pathway all exhibit relatively high leucine uptake and BCDC activity assessed by 14 CO 2 evolved from ␣-ketoisocaproate. The remaining tissues have little or no Leu3 Glu activity, owing to a number of patterns. The liver, kidney, and heart exhibit much reduced leucine uptake and metabolism to CO 2 , although the BCDC activity is high. The jejunum, and less markedly the thymus, have relatively little BCDC activity but take up leucine well. Skeletal muscle and cerebral cortex exhibit little uptake or BCDC activity.
Contractile prominent increases in tension owing to treatment with 5.0 mM leucinol of individual segments precontracted, respectively, with 10 Ϫ7 M phenylephrine or 5 M 5-HT. Figure 5 , AЈ and BЈ, shows the marked attenuation of these responses in corresponding, adjacent segments denuded of endothelium and treated similarly. The peak increments in tension owing to leucinol were proportional to the concentration tested in the range of 0.2-5.0 mM, as shown in Fig. 6 , and the values were similar for segments precontracted with either 10 Ϫ7 M phenylephrine (10 rats, 24 trials, F ϭ 43.6, P Ͻ 0.005) or 5 M 5-HT (8 rats, 12 trials, F ϭ 23.6, P Ͻ 0.005). The control, mean tension value before addition of 5 mM leucinol, 312 Ϯ 22 g/g wet wt, was increased by ϳ264 g/g wet wt, or 84.6%, by leucinol treatment. When four additional segments (2 rats) were denuded of endothelium and tested similarly, 5 mM leucinol elicited a much smaller increment, 50 Ϯ 24 g/g, significantly less than the increment observed with intact segments (t ϭ 4.66, P Ͻ 0.001).
Two experimental approaches were adopted to examine whether leucinol increases contractility by inhibiting endothelial NO formation. Aortic segments precontracted with 10 Ϫ7 M phenylephrine were tested for relaxation responses to 10 Ϫ5 M acetylcholine in the absence and presence of 1 or 5 mM leucinol. Values of the percent relaxation observed in six control versus four treated segments, 64.8 Ϯ 6.2% versus 66.6 Ϯ 6.3%, respectively, were not significantly different. The effects of 5 mM leucinol on segments precontracted as above were also examined in the absence and presence of 2 mM L-NAME added to inhibit NO formation. Whereas L-NAME abolished the relaxation responses to acetylcholine, it did not alter significantly the leucinol-induced increments in tension, with observed values for control versus L-NAME-treated segments of 230 Ϯ 66 versus 170 Ϯ 53 g/g (4 trials, P Ͼ 0.40).
L-Leucinamide (2-10 mM) also increased the contractile responses of segments precontracted with 10 M 5-HT. In seven trials (5 rats) treatment with 10 mM leucinamide yielded tension increments of 291 Ϯ 34 g/g (t ϭ 8.64, P Ͻ 0.001), a mean increase of 130%. When four segments were denuded of endothelium and tested similarly, the leucinamide-induced increment was decreased by ϳ79% to 61 Ϯ 32 g/g (t ϭ 4.50, P Ͻ 0.005). The effects of leucinamide on individual segments are illustrated in Fig. 5C (endothelium intact) and Fig. 5CЈ (endothelium denuded).
Contractile responses: effects of ␣-ketoisovalerate and L-valine. The catabolism of L-valine is initiated by its conversion to ␣-ketoisovalerate, which is then oxidatively decarboxylated by the same BCDC, which acts on ␣-ketoisocaproate derived from leucine (36) . Inasmuch as the valine and ␣-ketoisovalerate metabolic pathway does not yield acetyl CoA or glutamate, these compounds will competitively inhibit the functions of the Leu3 Glu pathway by preempting the BCDC. Accordingly, their effects on aortic contractile responses were examined in segments precontracted with phenylephrine, and the results are listed in Table 3 and illustrated for individual segments in Fig. 5 , D,DЈ and E,EЈ. In tests of 17 segments (10 rats) precontracted with 10 Ϫ7 M phenylephrine, treatment with 10 mM ␣-ketoisovalerate increased the tension values by 101 Ϯ 12 g/g (P Ͻ 0.001), or ϳ42% on average, and similar increments were observed in 9 additional trials (4 rats) of segments precontracted with 10 Ϫ6 M phenylephrine (P Ͻ 0.001). By contrast, five segments (3 rats) denuded of endothelium showed no significant change in tension on treatment with 10 mM ␣-ketoisovalerate (P Ͻ 0.001 for difference from intact segments), although they contracted normally on exposure to 10 Ϫ7 M phenylephrine (Table 3 ). In tests of 16 segments (6 rats) precontracted with 10 Ϫ6 M phenylephrine, treatment with 2 mM L-valine increased the tension values by 45 Ϯ 6 g/g (P Ͻ 0.001), or ϳ16% on average, and significant increments (P Ͻ 0.001) were also observed in eight further trials (4 rats) after precontraction with 10 Ϫ7 M phenylephrine. Again, denuding the endothelium of three segments (2 rats) eliminated the effect of valine (P Ͻ 0.001 for difference from intact segments), although the contractile responses to phenylephrine were intact (Table 3) .
Inasmuch as BCDC activity exhibits the characteristic aortic pattern of peak activity just distal to the aortic arch and decreasing activity distally, we tested whether increases in contractile responses owing to preemption of the enzyme by ␣-ketoisovalerate or valine follow a similar pattern. Successive aortic segments were tested as described above with 10 mM ␣-ketoisovalerate or 2 mM valine, and the increments in tension were plotted versus mean distance from the aortic valve ring. As shown in Fig. 7 , the patterns are similar to that observed for BCDC activity: highest values in the segments ϳ12-26 mm from the aortic ring, just distal to the arch, and decreasing values distally.
The increments in tension observed with ␣-ketoisovalerate do not result from inhibition of the endothelial NO pathway. Values of the percent relaxation of six control segments precontracted with 10 Ϫ6 M phenylephrine and treated with 10 Ϫ5 M acetylcholine, 64.8 Ϯ 6.2%, were not significantly different from those of six adjacent segments tested similarly in the presence of 10 mM ␣-ketoisovalerate, 70.1 Ϯ 4.4%. Furthermore, the presence of 2 mM L-NAME to block NO formation did not decrease responses to ␣-ketoisovalerate. The increments in tension owing to ␣-ketoisovalerate in two control and two adjacent L-NAME-treated segments, respectively, were 107 Ϯ 0.28 and 163 Ϯ 0.06 g/g.
␣-Ketoisovalerate also enhanced the contractile responses of segments precontracted with norepinephrine or 5-HT. In tests of four segments precontracted with 10 Ϫ7 M norepinephrine, the addition of 10 mM ␣-ketoisovalerate yielded tension increments of 81.8 Ϯ 21.1 g/g (P Ͻ 0.025). In tests of six pairs of adjacent segments precontracted with 10 M 5-HT, 10 mM ␣-ketoisovalerate increased both the duration of the contractile response (controls, 79 Ϯ 7 min; treated, 107 Ϯ 10 min; P Ͻ 0.01) and the total response, i.e., the area under the response curve (controls, 80.8 Ϯ 21.1 g/min; treated, 127.3 Ϯ 31.8 g/min; P Ͻ 0.02).
Segments precontracted with 10 Ϫ7 M phenylephrine were further tested with ␣-ketoisocaproate, the intermediate of the Leu3 Glu pathway. Although similar in chemical structure to ␣-ketoisovalerate, 5-10 mM ␣-ketoisocaproate did not significantly increase tension values in five tests but did eliminate contractile responses to 5-10 mM ␣-ketoisovalerate in four trials.
Contractile responses: effects of D-aspartate. Glutamate formed via the endothelial Leu3 Glu pathway is transported to the underlying smooth muscle coats. Interruption of the Leu3 Glu pathway by D-aspartate, a relatively specific and metabolically inert inhibitor of Na ϩ -dependent glutamate transporters (17, 28, 42) , Values are means Ϯ SE; n, no. of segments tested. Segments were precontracted with the indicated concentration of phenylephrine and test inhibitor was then added (see MATERIALS AND METHODS). Tension before inhibitor (a) was the value at the time of addition of the test inhibitor, and tension after (b) was the peak value thereafter. * P Ͻ 0.001 (t-test of paired comparisons) for b-a differences, i.e., effect of the test inhibitor, in intact segments. † P Ͻ 0.0125 (t-test of paired comparisons) for effect of the test inhibitor. ** P Ͻ 0.001 (t-test of unpaired comparisons) for b-a value differences between denuded and intact segments. Fig. 7 . Increments in tension of successive aortic segments precontracted with phenylephrine and treated with 10 mM ␣-ketoisovalerate (13 rats, 36 segments) or 2 mM L-valine (9 rats, 29 segments). Values are means Ϯ SE. Segments 7-mm long were precontracted and tested as described in Table 3 . Values for tension increments were plotted at the midpoint of each segment tested. The aortic arch, 0-12 mm from the aortic ring, was not tested. also enhanced contractile responses. Fifty-two segments (9 rats) precontracted with 10 Ϫ6 M phenylephrine were tested with various concentrations of D-aspartate, from 2-20 mM. Figure 5 , F and 5FЈ illustrates responses of an intact and an endothelium-denuded segment. Figure 8 shows that increments in tension were observed throughout the concentration range tested (F ϭ 11.36, P Ͻ 0.005) and increased from 44 Ϯ 6 g/g (ϳ15.6%) at 2.0 mM to 131 Ϯ 11 g/g (ϳ46.5%) at 20 mM. In five segments denuded of endothelium 20 mM D-aspartate treatment increased the tension by only 21 Ϯ 2.9 g/g (Fig. 8) , a decrease of ϳ84% compared with the intact segments (P Ͻ 0.001). Treatment of two segments with 2 mM L-NAME, followed by 20 mM D-aspartate, yielded tension increments of 131 Ϯ 2 g/g, similar to the control values. Precontraction of six segments with 10 M 5HT, followed by 2-20 mM D-aspartate, yielded tension increments comparable to the foregoing values. Na ϩ L-cysteate, another competitive inhibitor of glutamate transport, also elicited contractile responses. On addition of 20 mM L-cysteate to three aortic segments precontracted with 10 Ϫ6 M phenylephrine, the initial tensions, 219 Ϯ 13 g/g, increased to 420 Ϯ 54 g/g (P Ͻ 0.01).
Contractile responses: effects of external L-glutamate. Because inhibition of the Leu3 Glu pathway enhances contractile responses, glutamate added externally is expected to induce relaxation responses, providing it permeates the Leu3 Glu compartment. The permeation, however, is poor (41), and addition of 0.2-5.0 mM L-glutamate to aortic rings precontracted with 10 Ϫ6 M phenylephrine yielded no consistent change in tension. Raising the glutamate concentration to 10-20 mM, however, produced a biphasic response. In tests of 11 segments (4 rats) so treated versus 7 untreated adjacent segments, external glutamate elicited a rapid increase in tension (from initial values of 411 Ϯ 28 to 506 Ϯ 17 g/g), which persisted for 39 Ϯ 4 min and was followed by a prolonged relaxation. The glutamatetreated segments relaxed at a rate of 2.30 Ϯ 0.28 g ⅐ g Ϫ1 ⅐ min Ϫ1 compared with a slower rate in the untreated segments, 0.71 Ϯ 0.12 g ⅐ g Ϫ1 ⅐ min Ϫ1 (P Ͻ 0.001). The relaxation responses to glutamate were similar and significant whether the aortic segments were precontracted with 10 Ϫ6 M phenylephrine alone (4 trials, P Ͻ 0.01), or with phenylephrine, followed by either 20 mM D-aspartate (3 trials, P Ͻ 0.025) or 20 mM Na ϩ cysteate (4 trials, P Ͻ 0.0125). Denuding the endothelium had no significant effect on the responses to glutamate.
DISCUSSION
The results above demonstrate that the aortic Leu3 Glu pathway proceeds via the catabolism of leucine to acetyl CoA and acetoacetate, a metabolic route established by studies of other tissues (12, 34, 47) . In the rat aorta, this pathway comprises uptake of L-leucine at the luminal membrane of the endothelial cell by a Na ϩ -dependent mechanism (Fig. 4) ; transamination to ␣-ketoisocaproate, either in the cytosol or after transport across the mitochondrial membrane (20) ; oxidative decarboxylation to isovaleryl CoA by the BCDC of the mitochondrial matrix; successive dehydrogenation, carboxylation and hydration reactions to yield HMG CoA; and cleavage of HMG CoA to acetyl CoA and acetoacetate. In the presence of oxaloacetate, derived in our experiments from glucose metabolism, the acetyl CoA can be used to synthesize ␣-ketoglutarate via tricarboxylic acid cycle reactions and this product converted to glutamate by transamination or a glutamate dehydrogenase reaction. As a consequence of the catabolic pathway [1- (Fig. 1) , respectively, corresponds to the number of labeled carbon atoms in each amino acid available for acetyl CoA formation, i.e., 5:2:0.
The efficiency of conversion of leucine to glutamate, the stoichiometry of the process and the controlling role of the BCDC reaction were characterized by quantification of the 14 CO 2 evolved from the metabolism of [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]leucine, ␣-keto-[1-
14 C]isocaproate, and [U-14 C]-leucine. As shown in Figs. 2 and 3 , leucine metabolism to CO 2 occurs primarily in the endothelium and follows the regional differentiation pattern characteristic of the Leu3 Glu pathway. In the segments of peak activity ϳ25-40% of the leucine taken up from the ambient medium was oxidatively decarboxylated, and for each mole so metabolized there resulted 1 mol of glutamate plus 4 mol of CO 2 (Table 1) . Aortic segments, therefore, are relatively efficient at utilizing acetyl CoA derived from leucine for glutamate formation. One mechanism accounting for the efficiency is the relatively direct The Leu3 Glu, NO, and PGH 2 signal pathways share a similar regional pattern of activity in the rat aorta (1, 40, 41) , suggesting that the windkessel area, site of the maximal activity, is functionally specialized for regulating contractility of the underlying smooth muscle. Hence we sought a controlling reaction in the leucine catabolic sequence whose activity would correspond to the Leu3 Glu regional pattern. We focused on the BCDC reaction, which controls leucine catabolic flux in a number of other tissues. As shown in Fig. 2B , endothelium-dependent oxidative decarboxylation of ␣-keto- [1- 14 C]isocaproate by the BCDC in successive aortic segments clearly exhibits the regional pattern. Furthermore, we calculated the extent to which the differences in endothelium-dependent BCDC activity between the five successive segments shown in Fig. 2B could account for the corresponding segment-dependent differences in overall Leu3 Glu activity, i.e., glutamate formation (Fig. 3) . Let a represent values of the differences between the mean, endothelium-dependent BCDC activities of the successive aortic segments, estimated as the 14 CO 2 produced from ␣-keto-[1-
14 C]isocaproate and expressed relative to the peak 14 CO 2 producton (Fig. 2B) . Let b represent the corresponding values for the differences between the mean, endothelium-dependent Leu3 Glu activities of the successive aortic segments, estimated as the glutamate produced and expressed relative to the peak glutamate production (Fig. 3) . The ratio b/a then expresses the dependence of the segmental differences in overall Leu3 Glu activity on the differences in BCDC activity, and a value of 1.0 represents complete dependence (22) . The observed b/a values for four segmental differences (means Ϯ SE) are 1.01 Ϯ 0.06, in accord with complete dependence on the BCDC activity.
In contrast with the close correspondence of the Leu3 Glu and BCDC regional patterns of activity, no such pattern was observed for leucine-␣-ketoglutarate or alanine-␣-ketoglutarate transaminase activities in aortic homogenates of successive segments. Additon of ␣-ketoglutarate to the incubation medium composed of segments incubated with [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]leucine yielded no increase in 14 CO 2 production and no change in the regional pattern shown in Fig. 2A , consistent with the conclusion that leucine-␣-ketoglutarate net transamination to yield ␣-ketoisocaproate is not rate limiting in these segments. Two distal reactions of the leucine catabolic pathway also showed no regional segmental differences. Incubation of successive aortic segments with 1.7 M [9,10- 14 C]glutamate averaging 39 Ϯ 2 nmol/g and no significant segmental differences. The evidence, therefore, favors the BCDC reaction as the determinant of the regional activity pattern of the Leu3 Glu pathway. Specific factors that influence this reaction and could determine the regional pattern include the amount of BCDC enzyme protein, the degree of phosphorylation determining the activity state of the enzyme (19) , the availability of the ␣-ketoisocaproate substrate owing to net transamination of leucine, the transport of ␣-ketoisocaproate across the mitochondrial membrane via the branched chain ␣-ketoacid transporter (20) , and the concentration of cofactors required for the oxidative decarboxylation.
Estimations of the total free glutamate content of aortic segments incubated in vitro indicate that the endothelial Leu3 Glu pathway is a major determinant of that content. Thus the segmental values exhibit the characteristic regional pattern of the pathway, and in the peak segment (ϳ20-40 mm from the aortic valve ring) denuding the endothelium before incubation decreased the content by ϳ72%. Moreover, incubation with the Leu3 Glu pathway inhibitor L-leucinol decreased the value by ϳ51%. When the segments were denuded of endothelium after incubation, the underlying coats retained the glutamate. Similarly, denuding the endothelium before incubation markedly reduced the formation of [ 14 Leucine catabolism has been studied extensively in nonaortic tissues in relation to energy metabolism (12, 14) , protein synthesis and degradation (5, 37) , and familial disorders such as maple syrup urine disease (11, 27) and isovaleric acidemia (48) , which result from genetic defects in the BCDC and isovaleric dehydrogenase, respectively. Normal diets provide the human and the rat with an excess of the branched-chain amino acids, considerably more than is required for new protein synthesis in both growing and nongrowing individuals (14) . The leucine catabolic pathway therefore functions in nonaortic tissues as an essential disposal route for potentially toxic branched-chain intermediates, simultaneously providing calories for immediate use or storage as adipose tissue (14) . Several variables, including starvation (13, 19) , dietary protein level (19) , diabetes mellitus (3), octanoate infusion (4), and insulin and growth hormone (14) modulate flux through the pathway, with the direction of change dependent on the particular tissue. Generally, the controlling enzyme in these responses is the BCDC, whose activity is decreased by covalent phosphorylation and increased by dephosphorylation (12, 19) . In rat aortic endothelium the leucine catabolic pathway is utilized to supply acetyl CoA for glutamate synthesis and transfer to the underlying smooth muscle.
We tested the hypothesis that the Leu3 Glu pathway, along with the NO and PGH 2 pathways, functions to regulate the contractility of the aortic smooth muscle. Because leucinol and leucinamide interrupt the pathway and decrease the cGMP content of the smooth muscle, we predicted they would enhance aortic contractile responses, and the results above confirm the prediction. The enhanced responses require an intact endothelium and do not occur via reductions in NO formation or action. The specificity of action of these compounds is an important consideration because millimolar concentrations are required. Consequently we also tested two additional classes of Leu3 Glu pathway inhibitors, compounds that are chemically different from the leucine analogs and from each other. ␣-Ketoisovalerate and its precursor L-valine were chosen to preempt competitively the endothelial BCDC. These compounds, too, act on the endothelium to enhance contractile responses and the effects exhibit a regional aortic pattern (Fig. 7 ) similar to that of the BCDC activity (Fig. 2) . Specificity for the interruption of the Leu3 Glu pathway at the BCDC site is also indicated by the observations that ␣-ketoisocaproate, the BCDC substrate derived from leucine, does not enhance contractile responses but does block the inhibition owing to ␣-ketoisovalerate. ␣-Ketoisovalerate produced contractile responses in the presence of L-NAME and did not interfere with acetylcholine-induced relaxations. Hence the effects of ␣-ketoisovalerate are not mediated by blocking NO formation or action.
Interrupting the Leu3 Glu pathway by treatment with D-aspartate, a metabolically inert compound that competes with L-glutamate for transfer mediated by certain glutamate transporters, also causes enhanced contractile responses. These effects require an intact endothelium and do not result from reductions in NO formation. The results point to the involvement of glutamate transporters in the terminal steps of the pathway in which glutamate is transferred efficiently to the underlying coats without significant exchange with the extracellular medium. The mechanisms, membrane transporters, and routes responsible for this compartmentalized transport are unknown at present, and the precise locus of action of D-aspartate in the endothelium remains to be determined. In studies of nonaortic tissues, transport mechanisms with specificity for both L-glutamate and D-aspartate have been found in mitochondrial (29) and plasma membranes (10) . The X AG Ϫ family of glutamate/D-aspartate transporters (10) , which mediate Na ϩ -dependent transport across plasma membranes, have been particularly well characterized and a number cloned (43, 46) . These function prominently, for example, in glial and neuronal cells of the central nervous system where efficient cellular uptake of glutamate is essential to maintain low extracellular concentrations and prevent indiscriminate signaling and nerve damage (17) . It is reasonable to suggest that the compartmentalized transport of glutamate synthesized in the aortic Leu3 Glu pathway is also necessary for discrete signaling, particularly because free glutamate is relatively abundant in blood and many tissues.
Relatively high concentrations, 10-20 mM, of externally added glutamate elicited a rapid-onset increase of ϳ23% in tension followed, after a delay of ϳ39 min, by a prolonged relaxation response. The high concen- trations required and the slow onset of the relaxation responses could result from the relative impermeability to glutamate of the Leu3 Glu pathway. In prior studies glutamate treatment (0.5-2.0 mM) of rat aortic segments did increase cGMP levels but only when the segments were denuded of endothelium and treated with 3-isobutyl-1-methylxanthine to inhibit cyclic nucleotide phosphodiesterase (41) . Precontracted rabbit aortic rings were reported to exhibit relaxation responses on treatment with 100 mM glutamate or 1-10 mM glutamine (33) . Systematic studies (1, 40, 41) of sequential rat aortic segments in vitro provide comprehensive evidence of regional differentiation of the aortic endothelium. Figure 9 illustrates the patterns observed for six activities whose values peak in the windkessel area and decrease distally: constitutive formation of NO from L-arginine (1), cGMP content (1), and increase in cGMP owing to inhibition of the cyclooxygenase arm of the eicosanoid pathway and PGH 2 formation (40), endothelial uptake of [U- 14 C]leucine and its conversion to [ 14 C]glutamate (41), free glutamate content, and BCDC activity (Fig.  2) . The increase in values from the aortic arch (first ϳ12 mm from the valve ring) to the windkessel area are noteworthy in view of the ultrastructural studies utilizing morphometric methods reported by Kao et al. (23) . They observed that rat endothelial cells in the aortic arch are longer and thinner and contain fewer intracytoplasmic vesicles and fewer complex interdigitating intercellular contacts than those in the windkessel area.
The particular activities illustrated in Fig. 9 and their peaks in the windkessel area make it reasonable to hypothesize that the regional pattern was evolved for dynamic regulation of the contractility and compliance of the aortic elastic reservoir. Although the functional significance of aortic compliance, which is a determinant of the systolic blood pressure and work of the left ventricle, has been recognized for many decades (18) , the introduction of new noninvasive methods for its determination in experimental animals and human subjects has increased interest and research in the subject. Cholley et al. (9) used transesophageal echocardiography with automated border detection in the dog to evaluate and compare aortic compliance per unit length at a proximal site, just distal to the origin of the left subclavian artery, with a distal site at the level of the diaphragm. Compliance was higher in the proximal site, concordant with prior evidence (16) and the patterns in Fig. 9 . Applications of ultrasound methods (7, 30) and magnetic resonance imaging (8) have characterized further a number of variables influencing aortic compliance. Some variables, such as those in aging, involve compositional and structural changes in the aortic wall, which decrease compliance chronically and irreversibly (18) . Other variables, including exercise (25) and treatment with estrogenic (8), antioxidant (26) , or antihypertensive (44) agents can enhance compliance dynamically by influencing biochemical processes like those in Fig. 9 . Further characterization of the molecular mechanisms underlying dynamic regulation is warranted, inasmuch as clinical studies indicate that decreased compliance is a significant risk factor for systolic hypertension, cardiovascular dysfunction and disease (6, 30, 45) .
